Literature DB >> 11316748

The insulin-like growth factor I receptor-induced interaction of insulin receptor substrate-4 and Crk-II.

M Karas1, A P Koval, Y Zick, D LeRoith.   

Abstract

Stimulation of the insulin or insulin-like growth factor (IGF)-I receptor results in activation of several signaling pathways. Proteins of the insulin receptor substrate (IRS) family play important roles in mediating these signaling cascades. To date, four members of the IRS family of docking proteins have been characterized. Recently, we have reported that stimulation of the IGF-I receptor in 293 HEK cells regulates interaction of the newly discovered IRS-4 molecule with the Crk family of proteins. In the present study, we characterize the molecular basis of these interactions. C- and N termini truncation analysis of IRS-4 demonstrated that the region between amino acids 678 and 800 of the IRS-4 molecule is involved in this interaction. This region contains a cluster of four tyrosines (Y(700), Y(717), Y(743), and Y(779)). We hypothesize that one or more of these tyrosines are involved in the interaction between the SH2 domain of the Crk-II molecule when IRS-4 is phosphorylated upon IGF-I receptor activation. Additional mutational analyses confirmed this hypothesis. Interestingly, none of these four tyrosines was individually critical for the interaction between Crk-II and IRS-4, but when all four tyrosines were simultaneously mutated to phenylalanine, the IGF-I induced interaction between these molecules was abolished. Taken together, these results suggest a novel mechanism of Crk-II binding to tyrosine phosphorylated proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316748     DOI: 10.1210/endo.142.5.8135

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Insulin receptor substrate 4 couples the leptin receptor to multiple signaling pathways.

Authors:  Joris Wauman; Anne-Sophie De Smet; Dominiek Catteeuw; Denise Belsham; Jan Tavernier
Journal:  Mol Endocrinol       Date:  2007-12-28

2.  Sensitization and translocation of TRPV1 by insulin and IGF-I.

Authors:  Jeremy J Van Buren; Satyanarayan Bhat; Rebecca Rotello; Mary E Pauza; Louis S Premkumar
Journal:  Mol Pain       Date:  2005-04-27       Impact factor: 3.395

3.  Crk II silencing down-regulates IGF-IR and inhibits migration and invasion of prostate cancer cells.

Authors:  Pooja Dhupkar; Huang Zhao; Kalpana Mujoo; Zhiqiang An; Ningyan Zhang
Journal:  Biochem Biophys Rep       Date:  2016-10-28

4.  Expression and function of the insulin receptor substrate proteins in cancer.

Authors:  Katerina Mardilovich; Shannon L Pankratz; Leslie M Shaw
Journal:  Cell Commun Signal       Date:  2009-06-17       Impact factor: 5.712

5.  Identification by a differential proteomic approach of the induced stress and redox proteins by resveratrol in the normal and diabetic rat heart.

Authors:  D H W Dekkers; K Bezstarosti; N Gurusamy; K Luijk; A J M Verhoeven; E-J Rijkers; J A Demmers; J M J Lamers; N Maulik; D K Das
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

6.  Abnormal proinflammatory and stressor environmental with increased the regulatory cellular IGF-1/PAPP-A/STC and Wnt-1/β-Catenin canonical pathway in placenta of women with Chronic venous Disease during Pregnancy.

Authors:  Miguel A Ortega; Oscar Fraile-Martínez; Miguel A Saez; Miguel A Álvarez-Mon; Ana M Gómez-Lahoz; Coral Bravo; Juan A De León Luis; Felipe Sainz; Santiago Coca; Ángel Asúnsolo; Jorge Monserrat; Luis G Guijarro; Melchor Álvarez-Mon; Julia Bujan; Natalio García-Honduvilla
Journal:  Int J Med Sci       Date:  2021-05-27       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.